BOCH
PYXS icon

Blue Owl Capital Holdings’s Pyxis Oncology PYXS Stock Holding History

Blue Owl Capital Holdings’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,126,025
Closed -$4.13M – 106
2024
Q3 		$4.13M Buy
1,126,025
+80,000
+8% +$280K 0.8% 28
2024
Q2 		$3.46M Buy
+1,046,025
New +$4.4M 0.96% 23

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Blue Owl Capital Holdings's PYXS Position: Q4 2024 in Review

Blue Owl Capital Holdings sold out of Pyxis Oncology (PYXS) in Q4 2024, closing a stake of 1,126,025 shares — an estimated $4.13M sold.

Blue Owl Capital Holdings first reported a position in PYXS in Q2 2024 and held it in 2 quarters. The position peaked at $4.13M in Q3 2024. 99 funds tracked by Wall St. Rank hold PYXS as of Q4 2024.

  • Blue Owl Capital Holdings reported no remaining Pyxis Oncology position as of Q4 2024 after selling out during the quarter.
  • Blue Owl Capital Holdings sold 1,126,025 Pyxis Oncology shares in Q4 2024, an estimated $4.13M.
  • Blue Owl Capital Holdings first reported a position in Pyxis Oncology in Q2 2024 and held it in 2 quarters.
  • Blue Owl Capital Holdings's Pyxis Oncology position peaked at $4.13M in Q3 2024.
  • 99 funds tracked by Wall St. Rank held Pyxis Oncology as of Q4 2024.

Based on Blue Owl Capital Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.